GT Apeiron Therapeutics Company
GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology.
Headquarters:
Shanghai, Shanghai, China
Industry:
Early Drug Development
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Investors Number:
1.0
Technology:
Biotechnology, Health Care, Therapeutics
Last Funding Type:
Venture - Series Unknown
Founded Date:
2019-01-01
Total Funding:
27000000.0
Last Funding Date:
2019-06-11